WASHINGTON — The Trump administration is pulling its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton.
The decision follows concerns that Overton, a preventive care doctor who served in the Trump White House, lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination Wednesday. However, late on Tuesday, the panel’s leader, Sen. Bill Cassidy (R-La.), said Overton had sufficient support to clear his committee and win confirmation.
“Tonight, the White House abandoned a viable confirmation path for Dr. Overton,” Cassidy said in a post on X.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
View All Plans
